Biomarin Pharmaceutical Inc banner

Biomarin Pharmaceutical Inc
XMUN:BM8

Watchlist Manager
Biomarin Pharmaceutical Inc Logo
Biomarin Pharmaceutical Inc
XMUN:BM8
Watchlist
Price: 46.355 EUR
Market Cap: €8.8B

Intrinsic Value

The intrinsic value for Biomarin Pharmaceutical Inc (BM8) under the Base Case is 69.032 EUR. Compared with the current market price of 46.355 EUR, the stock appears Undervalued by 33% .

BM8 Intrinsic Value
69.032 EUR
Undervaluation 33%
Intrinsic Value
Price €46.355
Bear Case
Base Case
Bull Case
Monitor BM8
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €55.23
Get notified when the price drops into your buy zone
Intrinsic Value €69.03
Margin of Safety 20% €55.23
Current Price €46.36
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Ask AI Assistant
What other research platforms think about BM8?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is BM8 valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Biomarin Pharmaceutical Inc.

Explain Valuation
Alternatives to BM8

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

BMRN Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one BM8 stock?

The intrinsic value for Biomarin Pharmaceutical Inc (BM8) under the Base Case is 69.032 EUR.

Is BM8 stock undervalued or overvalued?

Compared with the current market price of 46.355 EUR, the stock appears Undervalued by 33% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett